Patents by Inventor Erika Glusa

Erika Glusa has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods of using 1-allyl ergot alkaloid derivatives to treat migraines
    Patent number: 7622476
    Abstract: This invention relates to 1-allyl ergot alkaloids and their derivatives with selective antagonistic properties to 5-HT2 receptors for the prevention of, and relief from, migraine-related headache, Parkinson's disease, disorders of the thrombocyte function, etc.
    Type: Grant
    Filed: December 21, 2002
    Date of Patent: November 24, 2009
    Assignee: Axxonis Pharma AG
    Inventors: Miroslav Flieger, Heinz Pertz, Karel Kranda, Jan Cvak, Sven Jaenichen, Erika Glusa
  • 1-allyl ergot alkaloid derivatives, methods for producing the same and the use thereof for preventing and treating migraine
    Publication number: 20060014774
    Abstract: This invention relates to 1-allyl ergot alkaloids and their derivatives with selective antagonistic properties to 5-HT2 receptors for the prevention of, and relief from, migraine-related headache, Parkinson's disease, disorders of the thrombocyte function, etc.
    Type: Application
    Filed: December 21, 2002
    Publication date: January 19, 2006
    Inventors: Miroslav Flieger, Heinz Pertz, Karel Kranda, Jan Cvak, Sven Jachnichen, Erika Glusa
  • Ergoline amine derivatives with blood pressure lowering effect
    Patent number: 6358967
    Abstract: The invention relates to novel derivatives of ergoline of the general formula 1 in which R1 together with the two adjacent N atoms is the residue of a diamine and R4 together with the two adjacent carbonyl groups is the residue of a dicarboxylic acid. R2, R3, R6, R7, R8 can be H or an organic radical. R7 and R8 are H or together are a bond. The compounds show a strong antihypertensive effect. These effects moreover occur after intravenous and enteral administration even at dosages in the region of a few &mgr;g/kg (body weight). The compounds can accordingly be used as pharmaceuticals for hypertensive diseases in human medicine.
    Type: Grant
    Filed: April 19, 2001
    Date of Patent: March 19, 2002
    Assignee: CyBio Screening GmbH
    Inventors: Ralf Wyrwa, Albert Haertl, Erika Glusa, Susanne Grabley, Ralf Thiericke